Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13D Filing: Wynnefield Partners Small Cap Value Lp I and Omega Protein Corp (OME)

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Wynnefield Partners Small Cap Value 496,797 0 496,797 0 496,797 2.2%
Wynnefield Partners Small Cap Value 814,807 0 814,807 0 814,807 3.7%
Wynnefield Small Cap Value Offshore Fund, Ltd. (No 103,890 0 103,890 0 103,890 0.5%
Wynnefield Capital, Inc. Profit Sharing Money Purchase Plan 75,000 0 75,000 0 75,000 0.3%
Wynnefield Capital Management 1,311,604 0 1,311,604 0 1,311,604 5.9%
Wynnefield Capital, Inc. 13-3688495 103,890 0 103,890 0 103,890 0.5%
Nelson Obus 0 1,490,494 0 1,490,494 1,490,494 6.7%
Joshua Landes 0 1,490,494 0 1,490,494 1,490,494 6.7%

Page 1 of 16 SEC Filing



Washington, D.C. 20549



(Amendment No. 3)

Under the Securities Exchange Act of 1934


 (Name of Issuer)

Common Stock, $0.01 par value

 (Title of Class of Securities)


( CUSIP Number)

Wynnefield Partners Small Cap Value,
L.P. I

450 Seventh Avenue, Suite 509

New York, New York 10123

Attention: Mr. Nelson Obus

Copy to:

Jeffrey S. Tullman, Esq.

Kane Kessler, P.C.

1350 Avenue of the Americas, 26th

New York, New York 10019

(212) 541-6222

(Name, Address and Telephone
Number of Person Authorized to Receive Notices and Communications)

February 23, 2016 

 (Date of Event which requires Filing
of this Statement)

If the filing person has previously filed
a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because
of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨

Follow Omega Protein Corp (NYSE:OME)
Trade (NYSE:OME) Now!